ARCHIVES

LabCorp Marketing Of Ovarian Cancer Test Unlawful, FDA Says In Warning Letter.

This article is from The Cancer Letter archive.

Vol. 34 No. 38 | October 17, 2008

Download PDF Visit The Full Archive

Related Articles

Varmus To Cut Five Percent From Cancer Centers As NCI Adjusts To “Financial disaster”

May 6, 2011

No More Free Cancergrams, But NCI Will Save a Bundle

October 17, 1986

DCE Board Approves Epidemiology Contract Recompetitions

March 17, 1995

Varmus, Branscomb Win Public Service Award From NSF; NCI Clarifies Plans For Large R01s

June 1, 2001

Clinical Trials System “Slowly Unraveling,”

March 7, 2008

In Brief: Monaco, Yarbro Named To Pharmacopeial Board; Gene Therapy Trial For ADA Clears First Hurdle

March 23, 1990